Hrt Financial LP Vista Gen Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $236,206 - $464,361	-268,417 Reduced 93.44%	18,857 $16,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $261,321 - $479,088	229,229 Added 394.92%	287,274 $356,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $96,935 - $160,204	58,045 New	58,045 $113,000
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $328,233 - $527,517	-167,466 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $316,510 - $495,699	167,466 New	167,466 $356,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.